A Solution for Overcrowded Emergency Departments for Patient with Symptoms of Heart Attack

Interactive Media Kit


Why cardiac testing matters in 2022: Facts and figures

Atellica VTLi Patient-side Immunoassay Analyzer Infographic for Media ©2022

17.7 million people die every year from Cardiovascular Diseases, an estimated 31% of all deaths worldwide.2

When a patient presents with symptoms of a potential heart attack, they and their families depend on everyone working together with speed and confidence for favorable outcomes. During those most critical moments, trust, time, and resources aren't just valuable—they're vital. Fast and accurate diagnosis can make all the difference to patients waiting to find out if they've had a heart attack.

Every minute waiting on test results comes at a cost when patients present to the emergency department with signs and symptoms that may indicate myocardial infarction (MI). 

Patients and their families are anxious, and clinicians and laboratory professionals are pressured to identify the problem quickly and accurately. Fear and anxiety are common emotions for anyone with heart conditions, and an acute onset of chest pain or other symptoms requiring emergency evaluation can exacerbate those feelings.3

Atellica VTLi Patient-side Immunoassay Analyzer Infographic for Media ©2022

Heart disease has remained the leading cause of death at the global level for the last 20 years.5

Many emergency departments today are overcrowded, leaving both patients and providers waiting for answers. How can this be improved? How can we increase efficiency and diagnostic confidence for clinicians?

Expediting triage times for patients presenting with heart attack symptoms enhances patient care and helps against Emergency Department overcrowding—a patient safety issue and a worldwide public health problem that contributes to cardiac deaths.4

Having high-sensitivity troponin I testing available at the bedside can transform the way chest pain patients are assessed, providing reliable results in just 8 minutes.


A vital leap forward in cardiac testing

Benefitting physicians and patients

Improved ED throughout Assessment

Optimized Emergency Department Wait Times

Streamlines chest pain assessment, aiding in earlier diagnosis for patients having a heart attack and peace of mind for those who are not.

Evidence-Based Accurate Performance

Evidence-Based, Accurate Results

Offers high-sensitivity Troponin I testing right at the bedside. Results are available in just minutes for patients, clinicians and laboratory partners.

Heart Assessment Monitor

Easily Integrated into Assessment Process

Transforms the chest pain assessment process to benefit patients and clinicians.


Videos: Expert perspectives

Dr. Paul Collinson is a professor of Cardiovascular Biomarkers and Former Consultant in Chemical Pathology at St George’s University Hospital

“With the Atellica VTLi system, we’re able to improve the patient pathway by combining rapid results with a process redesigned with the use of an ambulatory care area. We can use space more efficiently, and more importantly, we're going to get them out of hospital faster.”

DR. PAUL COLLINSON


What do respected clinicians have to say about Atellica VTLi Analyzer?

Dr. Frank Peacock

Professor, Vice Chair for Research, Henry JN Taub Department of Emergency Medicine, Baylor College of Medicine

Dr. Mike Samoszuk

Pathologist, Physician-Executive

Professor Gruson

Head of the Department of Clinical Biochemistry of the Cliniques Universitaires Saint-Luc 

Friedrich Fuchs

Senior Medical Officer (AT), Siemens Healthineers

Media Materials

Atellica VTLi Patient-side Immunoassay Analyzer Infographic for Media ©2022

This image is a preview. The complete infographic is available for download and may be republished with proper attribution (Graphic courtesy of Siemens Healthineers. ©2022 Siemens Healthcare Diagnostics Inc.).

Once a patient develops symptoms and seeks care at a hospital, their patient pathway begins. At that point, every minute counts.

Make this infographic available to your readers to help them understand the cardiac clinical pathway. If you republish, please provide proper attribution: 

Graphic courtesy of Siemens Healthineers. ©2022 Siemens Healthcare Diagnostics Inc.

Images available for the media

Attribution: Image courtesy of Siemens Healthineers. ©2022 Siemens Healthcare Diagnostics Inc.

The Atellica VTLi Patient-side Immunoassay Analyzer on white background

The Atellica VTLi Patient-side Immunoassay Analyzer delivers high-sensitivity troponin I results at the patient-side in 8 minutes.


Download hi-res image

Atellica VTLi hs-cTnI reagent cartridge & RFID Chip shown on a white background

The Atellica VTLi high-sensitivity troponin I reagent cartridge contains an RFID chip that contains expiry and lot specific data.


Download hi-res image

Siemens Atellica VTLi Analyzer shown on a white background

The Atellica VTLi hs-cTnI reagent cartridge contains an RFID chip that contains expiry and lot specific data.

Download hi-res image

Important Dates

American Heart Month

Every February

World Heart Day 2022

Thursday, 29 September 2022

Press Contact: Kimberly Nissen

Siemens Medical Solutions, Inc40 Liberty BoulevardMalvern, PA, 19355 

  1. Utility of the History of Physical Examination in the Detection of Acute Coronary Syndromes in Emergency Department Patients. Western Journal of Emergency Medicine. Volume 18, no. 4: June 2017. DOI: 10.5811/westje.2017.3.32666
  2. Screening of family members of pts. w/premature CAD, EUROASPIRE I- EHJ (2003);24: 249-257.
  3. Heart conditions and mental health. British Heart Foundation. https://www.bhf.org.uk/informationsupport/heart-matters-magazine/wellbeing/mental-health/mental-health-survey
  4. What we have learned from a decade of ED crowding research. Pines, JM, Griffey RT, Acad Emerg Med. 2015 Aug;22(8):985-7. doi: 10.1111/acem.12716. Epub 2015 Jul 20
  5. WHO reveals leading causes of death and disability worldwide: 2000-2019. World Health Organization, Pan American Health Organization. Epub 2020 Dec 9. https://www.paho.org/en/news/9-12-2020-who-reveals-leading-causes-death-and-disability-worldwide-2000-2019